Atlas Trials

Influenza Disease

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Influenza Disease

RecordFirmDate
Safety, Tolerability, and Immunogenicity of the Adjuvanted Trivalent Subunit Influenza Vaccine and the Non-Adjuvanted Trivalent Subunit Influenza Vaccine Compared to the Non-Adjuvanted Trivalent Split Influenza Vaccine in Children 6 to < 72 Months of Age (NCT01346592)Novartis Vaccines2011-04-01
Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2009/2010 Recommended in Northern Hemisphere in Non-elderly Adult and in Elderly Subjects (NCT00918268)Novartis Vaccines2009-06-01
Support Annual Strain Update, Safety and Immunogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases. (NCT00522067)Novartis Vaccines2007-06-01
Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-adjuvanted Inactivated Subunit Influenza Vaccine, When Administered to Adults Affected by Chronic Diseases (NCT00519064)Novartis Vaccines2006-11-01
Influenza Vaccination of Nursing Home Workers. (NCT00359554)Assistance Publique - Hôpitaux de Paris2006-09-01
Safety and Immunogenicity of a Inactivated Influenza Vaccine When Administered to Non Elderly Adults and Elderly Subjects. (NCT00316615)Novartis2005-06-01

Track Influenza Disease automatically

Every clearance here is in the API, with alerts when new ones post.